این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
جمعه 21 آذر 1404
Iranian Journal of Public Health
، جلد ۵۳، شماره ۷، صفحات ۱۶۱۲-۱۶۲۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Linoleic Acid Modulates the Expression of Metastatic and Angiogenic Markers MMP-2 and Talin-2 in Gastric Cancer Cell Line MKN-45
چکیده انگلیسی مقاله
Background: Linoleic acid (LA) has modulatory effects on gastric cancer cell lines. This study aimed to investigate the effects of linoleic acid on the expression of metastatic and angiogenic molecular markers in gastric cancer cell line MKN-45. Methods: In this study performed in Tabriz, Iran in 2021, MKN-45 cells were treated with LA in the presence or absence of docetaxel. Total RNA was extracted, and cDNA synthesized from the cells before and after treatment. The expression levels of Talin-2 and MMP-2 genes and mir-20, mir-30, mir-126, and mir-194, were determined by quantitative real-time PCR. Results: LA treatment reduced the expression levels of mir-126, mir-194, mir-30, and MMP-2, while increased the expression levels of Talin-2 mRNA. Docetaxel treatment could decrease the expression levels of mir-20, Talin-2, and MMP-2 mRNA levels while increasing the expression levels of mir-126, mir-194, and mir-30. Additionally, the combined treatment of MKN-45 cells with LA and docetaxel could reduce the expression levels of mir-20 and mir-126 and increased the expression levels of mir-194, mir-30, Talin-2, and MMP-2 mRNAs. Conclusion: Modulation of the expression levels of gastric cancer involved microRNAs, Talin-2, and MMP-2 may be a mechanism through which LA may exert its biological effects on GC cell line MKN-45. LA may have an antimetastatic effect by reducing the MMP-2 expression and pro-angiogenic effect through increasing Talin-2 expression levels.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
| Daniel Elieh-Ali-Komi
1. Institute of Allergology, Charité, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany 2. Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany
| Tohid Kazemi
1. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran 2. Department of Immunology, Tabriz University of Medical Sciences, Tabriz, Iran
| Najibeh Shekari
1. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran 2. Department of Immunology, Tabriz University of Medical Sciences, Tabriz, Iran
| Parviz Farzamifar
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
| Elham Eghbali
Medical Radiation Sciences Research Group, Tabriz University of Medical Sciences, Tabriz, Iran
| Behzad Mansoori
1. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran 2. Department of Immunology, Tabriz University of Medical Sciences, Tabriz, Iran
| Behzad Baradaran
1. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran 2. Department of Immunology, Tabriz University of Medical Sciences, Tabriz, Iran
| Masoud Shirmohamadi
1. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran 2. Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
نشانی اینترنتی
https://ijph.tums.ac.ir/index.php/ijph/article/view/30309
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات